Clinical Trial

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

Study acronym: SALOME
Recruiting
View on ClinicalTrials.gov →
Summary
Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-06-05; most recent amendment 2025-09-02.
Status change: Not Yet Recruiting → Recruiting 2020-12-14
Trial Details
NCT Number NCT04424719
Lead Sponsor Institut Curie
Conditions Uveal Melanoma
Enrollment 700 participants
Start Date 2020-07-08
Primary Completion 2037-07-07 (estimated)
Study Completion 2037-07-07 (estimated)
Updated on ClinicalTrials.gov 2025-09-03